EMA: EMA PUBLISHED THE ASSESSMENT REPORT FOR VEKLURY (REMDESIVIR) SUPPORTING ITS EXTENSION OF INDICATION TO INCLUDE ADULTS AT INCREASED RISK OF SEVERE COVID-19: 05/01/2022
Ema: Ema Published The Assessment Report For Veklury (Remdesivir) Supporting Its Extension Of Indication To Include Adults At Increased Risk Of Severe Covid-19: 05/01/2022
![Reuters logo](/images/reuters.jpg)